In one study, presented at this year’s Digestive Disease Week (abstract Su1268), researchers at the University of Pennsylvania found that PPIs were linked to an increased risk for pancreatic cancer. A second study published in the BMJ Open reported that military veterans who used PPIs had a small but significantly increased risk for premature death compared with those who took other reflux drugs or no such therapy. Read more . . .
Studies stoke debate over safety of the reflux drugs. New data are yet again casting a shadow over the safety of proton pump inhibitors.